Arthroscopic Biological Augmentation With Subacromial Bursa for Bursal Side Partial-thickness Rotator Cuff Tears

Sponsor
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization (Other)
Overall Status
Completed
CT.gov ID
NCT05823428
Collaborator
(none)
40
1
2
35
1.1

Study Details

Study Description

Brief Summary

The investigators aimed to compare the results of acromioplasty + arthroscopic debridement and acromioplasty + augmentation with subacromial bursa.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Augmentation with subacromial bursa + acromioplasty
  • Procedure: Rotator cuff debridement + acromioplasty
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Arthroscopic Biological Augmentation With Subacromial Bursa for Bursal Side Partial-thickness Rotator Cuff Tears
Actual Study Start Date :
Feb 1, 2019
Actual Primary Completion Date :
Jan 1, 2021
Actual Study Completion Date :
Jan 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Rotator cuff debridement + acromioplasty

Group A was formed by performing rotator cuff debridement + acromioplasty in 18 patients.

Procedure: Rotator cuff debridement + acromioplasty
Two intervention was planned. Rotator cuff debridement + acromioplasty group is mentioned as Group A (18 patients) and augmentation with subacromial bursa + acromioplasty is Group B

Active Comparator: Augmentation with subacromial bursa + acromioplasty

Group B was formed by performing augmentation with subacromial bursa + acromioplasty in 22 patients.

Procedure: Augmentation with subacromial bursa + acromioplasty
Two intervention was planned. Rotator cuff debridement + acromioplasty group is mentioned as Group A (18 patients) and augmentation with subacromial bursa + acromioplasty is Group B

Outcome Measures

Primary Outcome Measures

  1. Evaluation of biological augmentation with bursa using postoperative clinical scores and MRI. [18 months]

    Our Primary Outcome Measure is to investigate the effects of biological augmentation with subacromial bursa in arthroscopic bursal-sided partial thickness rotator cuff repair with postoperative MRI and functional scores with Constant-Murley and Ases scores.

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • bursal side rotator cuff tears in MRI sections

  • Patients whose pain does not go away despite NSAIDs and standardized physical therapy by the same physiotherapist applied for 3 months

  • 25-50% or 3-6 mm rotator cuff tear (Ellman grade 2) on the bursal side

Exclusion Criteria:
  • Previous surgery

  • tears greater than 50% or 6 mm

Contacts and Locations

Locations

Site City State Country Postal Code
1 SBU Prof. Cemil Tascioglu City Hospital Istanbul Turkey 34040

Sponsors and Collaborators

  • Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Bulent KARSLIOGLU, Orthopedics and Traumatology specialist,Chief assistant, Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
ClinicalTrials.gov Identifier:
NCT05823428
Other Study ID Numbers:
  • Subacromial bursa Augmentation
First Posted:
Apr 21, 2023
Last Update Posted:
Apr 21, 2023
Last Verified:
Apr 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Bulent KARSLIOGLU, Orthopedics and Traumatology specialist,Chief assistant, Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 21, 2023